Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Nature Communications|September 30, 2016
FoxO1 in dopaminergic neurons regulates energy homeostasis and targets tyrosine hydroxylaseKhanh V Doan, Ann W Kinyua, Dong Joo Yang, et al.Journal of Medicinal Chemistry|March 6, 2025
Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver FibrosisJihyeon Yoon, Won-Il Choi, Won Hee Lee, et al.Nature Communications|November 18, 2018
Serotonin signals through a gut-liver axis to regulate hepatic steatosisWonsuk Choi, Jun Namkung, Inseon Hwang, et al.Nature Communications|January 10, 2019
Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosisWonsuk Choi, Jun Namkung, Inseon Hwang, et al.Journal of Medicinal Chemistry|January 6, 2025
Synthesis and Biological Evaluation of Peripheral HTR2A Antagonists for Colorectal CancerMinhee Kim, Jihyeon Yoon, Jun Young Choi, et al.Diabetologia|February 10, 2015
Disruption of CR6-interacting factor-1 (CRIF1) in mouse islet beta cells leads to mitochondrial diabetes with progressive beta cell failureYong Kyung Kim, Kyong Hye Joung, Min Jeong Ryu, et al.Journal of Medicinal Chemistry|April 15, 2020
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver DiseaseMinhee Kim, Inseon Hwang, Haushabhau S Pagire, et al.Nature Communications|April 21, 2018
Reduced oxidative capacity in macrophages results in systemic insulin resistanceSaet-Byel Jung, Min Jeong Choi, Dongryeol Ryu, et al.Nature Communications|January 20, 2024
Discovery of a peripheral 5HT<sub>2A</sub> antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitisHaushabhau S Pagire, Suvarna H Pagire, Byung-Kwan Jeong, et al.Science Immunology|August 23, 2024
Mast cell-derived BH4 and serotonin are critical mediators of postoperative painPhilipp Starkl, Gustav Jonsson, Tyler Artner, et al.Pageof 9